Highlights N4 Pharma Plc

Equities

Market Closed - London S.E. Other stock markets 11:35:07 2024-07-03 am EDT			5-day change	1st Jan Change
0.425 ^GBX	0.00%		0.00%	-50.00%

Jul. 03	Topps Tiles sales dip; Physiomics completes placing	AN
Jun. 07	N4 Pharma raises GBP630,000 to advance primary work streams	AN

Topps Tiles sales dip; Physiomics completes placing	Jul. 03	AN
N4 Pharma raises GBP630,000 to advance primary work streams	Jun. 07	AN
N4 Pharma strikes partnership deal for intracellular delivery	Apr. 25	AN
N4 Pharma loss widens but "great optimism" remains	Apr. 23	AN
N4 Pharma Plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 23	CI
N4 Pharma sees potential in Nuvec delivery method for cancer treatment	Apr. 18	AN
N4 Pharma’s In Vivo Testing Shows Nuvec’s Potential as Oral Delivery System	Apr. 18	MT
N4 Pharma shares rise on "encouraging" Nuvec research	Feb. 15	AN
AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets	Feb. 15	AN
N4 Pharma plc Provides In-Vitro siRNA Update	Feb. 15	CI
N4 Pharma's Nuvec Granted Patent in India	Jan. 19	MT
N4 Pharma gets India patent for medical delivery system	Jan. 19	AN
N4 Pharma touts contract to test glaucoma treatment, ECP105	Jan. 16	AN
N4 Pharma hails increased efficacy of Nuvec when complexed with AAV8	Jan. 08	AN
N4 Pharma plc Provides A Further Successful Update on Its Ongoing Research Work into the Use of Nuvec to Enhance the Performance of Viral Vector	Jan. 08	CI
N4 Pharma Plc Provides Positive Update on its Ongoing Oral Delivery Research Work	Dec. 18	CI
N4 Pharma hails "encouraging" siRNA research	Dec. 07	AN
N4 launches investor hub; Capricorn production falls	Dec. 01	AN
N4 Pharma shares fall as places shares to fund Nanogenics stake buy	23-09-28	AN
N4 Pharma Buys 71% Stake in Biotechnology Company Nanogenics; Stock Plummets	23-09-28	MT

No results for this search